IBD

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Jan. 9, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Nov. 14, 2017

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Nov. 13, 2017

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

How Will Translational Advances in Pediatric IBD Affect Practices?

Oct. 17, 2017

Dr. Rosen will discuss how new findings can make a difference for pediatric IBD patients at the Crohn’s & Colitis Congress.

Stepped-Up Moves to Understand, Diagnose IBD-Related Autoimmune Pancreatitis

Oct. 12, 2017

Possible genetic overlap; concurrence shown to affect clinical course, pancreatic cancer risk.
Advertisement

Apply Biomarkers to Better Target Therapies to IBD Patients

Oct. 12, 2017

Dr. Lee A. Denson will present his findings on biomarkers in Las Vegas at the Crohn’s & Colitis Congress.

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

GIs Should be Able to Prescribe the Most Beneficial Treatments

Oct. 4, 2017

AGA supports Restoring the Patient’s Voice Act — new legislation that facilitates treatment appeals to insurance companies.

Blog: 3-D Imaging of T-Cell Localization in Inflamed Colon Tissues

Oct. 3, 2017

Researchers report that light sheet fluorescence microscopy (LSFM) can better assess IBD progression and the effects of therapeutic agents. Read more in the AGA Journals blog.

Biologic Therapy, Risk Estimation Dominate Pediatric IBD Research

Sept. 28, 2017

New findings show inflammatory bowel disease (IBD) is on the rise in children in North America.

Crohn’s & Colitis Congress Offers Reporters Access to Leading IBD Research

Sept. 20, 2017

Implementing AGA’s Newest IBD Guideline in Your Practice

Sept. 18, 2017

Experts will provide guidance around the latest IBD guidelines at the 2018 Crohn’s & Colitis Congress.™

IBD No Obstacle to Safe Pregnancy

Sept. 14, 2017

If IBD is in remission at conception and during gestation.

Blog: Could the Microbiota Link Metabolic Syndrome with Inflammation?

Sept. 14, 2017

Researchers report that an altered microbiota may cause inflammation by attaining greater proximity to epithelial cells. Read more on the AGA Journals blog.

Congressional Committees Approve Increase for NIH Funding

Sept. 13, 2017

Senate bill includes funding for gastrointestinal disorders and cancers.

RFP Issued to Identify Best Practices in IBD Shared-Decision Making

Sept. 13, 2017

Applications accepted from Sept. 11 through Oct. 13

Leading Patient Organizations Collaborate to Improve Patient Care in IBD Through Shared Decision-Making

Sept. 11, 2017

Share Your Cutting-Edge IBD Research

Sept. 11, 2017

The processing fee for oral and/or poster presentation is being waived. Submissions are due by October 31 at 9 p.m. ET.

Blog: Do Fatty Acids Increase Risk of Ulcerative Colitis Flares?

Sept. 6, 2017

Palm oil, coconut oil and dairy fats may increase flares according to prospective study of 412 patients. Read more on the AGA Journals blog.

American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Sept. 1, 2017

This document presents the official recommendations of the AGA on therapeutic drug monitoring in inflammatory bowel disease.

American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases

Sept. 1, 2017

This review focuses on the application of TDM for biologic therapy, specifically anti-tumor necrosis factor a agents, and for thiopurines.

Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis

Sept. 1, 2017

We associated combined treatment with immunomodulators with reduced risk of formation of antibodies against TNF antagonists in patients with IBD.